Trevi Therapeutics, Inc.
TRVI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$47,911 | -$29,065 | -$29,152 | -$33,940 |
| Dep. & Amort. | $147 | $123 | $43 | $50 |
| Deferred Tax | $0 | $0 | $0 | -$82 |
| Stock-Based Comp. | $3,588 | $2,247 | $2,327 | $2,543 |
| Change in WC | $6,827 | -$3,847 | -$1,231 | $1,509 |
| Other Non-Cash | -$907 | -$1,168 | -$162 | $974 |
| Operating Cash Flow | -$38,256 | -$31,710 | -$28,175 | -$28,946 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$35 | -$137 | -$159 | $0 |
| Net Acquisitions | $0 | $0 | -$829 | $0 |
| Inv. Purchases | -$98,463 | -$9,932 | -$126,215 | $0 |
| Inv. Sales/Matur. | $75,603 | $69,497 | $19,001 | $0 |
| Other Inv. Act. | $1,367 | $0 | $829 | $0 |
| Investing Cash Flow | -$21,528 | $59,428 | -$107,373 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$126 | -$9,409 | -$5,833 | -$68 |
| Stock Issued | $61,146 | $1,710 | $105,410 | $21,183 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $464 | -$211 | $11,730 | -$340 |
| Financing Cash Flow | $61,484 | -$7,910 | $111,307 | $20,775 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $1,700 | $19,808 | -$24,241 | -$8,171 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $32,397 | $12,589 | $36,830 | $45,001 |
| End Cash | $34,097 | $32,397 | $12,589 | $36,830 |
| Free Cash Flow | -$38,291 | -$31,847 | -$28,334 | -$28,946 |